The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma

Table 1 Immunotherapeutic Effect of DCs Vaccine in Mice with Pancreatic Carcinoma

	DC-IL18-Lysate I group	DC-Lysate II group	DC-IL18 III group	DC IV group	PBS V group
Tumor Weight (g)	0.22 ± 0.083a	1.45 ± 0.74bc	1.89 ± 1.34d	3.0 ± 1.6	2.9 ± 2.0
Median Survival (d)	> 62a	48.6 ± 9.4bc	33 ± 12.3d	17 ± 3.2	19.6 ± 5.4

^aP < 0.01, vs the other groups;

^bP < 0.05, vs III group;

^cP < 0.01, vs IV and V groups;

^dP < 0.05, vs IV and V group